News
Fighting Superbugs: How an Indian Avenger is building a life-saving weapon
Big pharma has little interest in antibiotics because there's not enough money in it, making Bugworks, with its R&D in India, among a handful of startups that is attempting the impossible
GARDP supports Bugworks in assessing safety of new antibiotic compound
Global Antibiotic Research and Development partnership (GARDp), a not-for-profit entity created by he WHO and DnDi, spearheading the fight against Antimicrobial Resistance (AMR), announces a collaboration with Bugworks via supporting the cardiac safety assessment studies of Bugworks' lead molecule BWC0977, currently going through Phase 1 studies in Adelaide Australia.
PM Modi hails biotech startups, praises $80 billion BioEconomy
The 10th Foundation Day of BIRAC was an occasion for the Prime Minister Mr Narendra Modi to praise the efforts of India’s vibrant $80 billion BioEconomy that grew by 14% during the Covid Pandemic in 2021.
.jpeg)
Praj Industries Executive Chairman Pramod Chaudhari wins the 2022 Holmberg Award for Lifetime Achievement in the Advanced Bioeconomy
In Florida, The Daily Digest announced that Praj Industries Executive Chairman Pramod Chaudhari will receive the 2022 William C. Holmberg Award for Lifetime Achievement in the Advanced Bioeconomy
Bugworks Research Inc. secures US$18M Series B1 Funding from Reputed Global Investor Syndicate (The EU, UK, Japan, South Africa & India), led by Lightrock India
This Funding will advance highly differentiated assets in the dual areas of Antimicrobial Resistance (AMR) and Immuno-Oncology (IO)
Exhibit in the 'India Pavilion' at BIO 2026
